NASDAQ · Financial Statements

Pro-Dex, Inc. (PDEX) Revenue, Earnings & Financial Statements

$61.93 NASDAQ: PDEX Market Cap $198.18M

Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

Pro-Dex, Inc. most recently reported annual revenue of $78.0M, net profit of $14.0M. Revenue grew at an average annual rate of 13.2% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Pro-Dex, Inc.: Revenue rose from $22.0M in 2017 to $78.0M in 2026, a change of +254.5% over 9 years; net profit was positive in all 10 reported years; operating margin moved from 12.5% to 16.8%, a shift of +4.3 percentage points; the most recent year shows net profit of $14.0M.

Income Statement — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Revenue$22.0M$22.0M$27.0M$35.0M$42.0M$42.0M$46.0M$54.0M$67.0M$78.0M
Operating Expenses$19.0M$20.0M$22.0M$28.0M$37.0M$37.0M$40.0M$47.0M$56.0M$65.0M
Operating Profit$3.0M$2.0M$5.0M$7.0M$5.0M$5.0M$6.0M$7.0M$11.0M$13.0M
Operating Margin12.5%10.7%18.4%20.3%12.2%12.2%12.5%13.3%16.1%16.8%
Other Income$0$0$0$1.0M$1.0M$1.0M$4.0M−$5.0M$1.0M$5.0M
Interest$0$0$0$0$0$0$1.0M$1.0M$1.0M$1.0M
Depreciation$1.0M$1.0M$0$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M
Profit Before Tax$3.0M$3.0M$5.0M$8.0M$6.0M$6.0M$9.0M$3.0M$12.0M$18.0M
Tax rate (%)-75.9%37.9%23.9%22.6%19.7%19.7%25.0%19.3%25.5%24.2%
Net Profit$5.0M$2.0M$4.0M$6.0M$5.0M$5.0M$7.0M$2.0M$9.0M$14.0M
EPS$1.25$0.37$0.97$1.50$1.13$1.21$1.95$0.60$2.67$4.12

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$13.0M$14.0M$15.0M$15.0M$17.0M$17.0M$17.0M$19.0M$19.0M$20.0M$20.0M$21.0M
Operating Expenses$12.0M$12.0M$13.0M$12.0M$14.0M$14.0M$16.0M$15.0M$15.0M$17.0M$17.0M$17.0M
Operating Profit$1.0M$2.0M$2.0M$3.0M$3.0M$4.0M$1.0M$3.0M$3.0M$3.0M$4.0M$4.0M
Operating Margin6.2%15.5%15.7%20.2%16.0%20.9%7.7%16.8%17.5%15.5%17.3%17.1%
Interest$0$0$0$0$0$0$0$0$0$0$0$0
Profit Before Tax$1.0M$1.0M$2.0M$3.0M$3.0M$5.0M$2.0M$6.0M$3.0M$5.0M$4.0M$3.0M
Tax rate (%)19.4%28.3%17.8%25.7%21.1%28.1%25.2%24.8%25.3%26.3%18.9%9.8%
Net Profit$1.0M$1.0M$2.0M$2.0M$2.0M$3.0M$1.0M$5.0M$2.0M$4.0M$3.0M$3.0M
EPS$0.14$0.19$0.46$0.75$0.61$0.98$0.36$1.40$0.66$1.20$0.86$0.92

Over the 10 years reported for Pro-Dex, Inc., cash stood at $8.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 4.08 times.

Balance Sheet — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Total Assets$16.0M$20.0M$26.0M$31.0M$49.0M$49.0M$52.0M$52.0M$61.0M$75.0M
Current Assets$12.0M$16.0M$22.0M$23.0M$31.0M$31.0M$31.0M$37.0M$47.0M$53.0M
Cash$4.0M$5.0M$8.0M$6.0M$1.0M$1.0M$3.0M$3.0M$0$8.0M
Inventory$3.0M$4.0M$6.0M$8.0M$13.0M$13.0M$16.0M$15.0M$22.0M$21.0M
Receivables$4.0M$4.0M$4.0M$5.0M$15.0M$15.0M$10.0M$14.0M$17.0M$21.0M
Fixed Assets$1.0M$2.0M$3.0M$6.0M$13.0M$13.0M$13.0M$13.0M$1.0M$1.0M
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$1.0M$2.0M$3.0M$5.0M$5.0M$5.0M$9.0M$6.0M$7.0M$2.0M
Other Assets$0$0$0$0$0$0$0$0$0$7.0M
Total Liabilities$3.0M$3.0M$9.0M$12.0M$24.0M$24.0M$20.0M$22.0M$25.0M$27.0M
Current Liabilities$3.0M$3.0M$4.0M$5.0M$11.0M$11.0M$10.0M$13.0M$15.0M$13.0M
Borrowings$0$0$5.0M$7.0M$16.0M$16.0M$15.0M$14.0M$17.0M$18.0M
Other Liabilities$3.0M$3.0M$4.0M$5.0M$8.0M$8.0M$5.0M$8.0M$8.0M$9.0M
Equity$18.0M$20.0M$16.0M$13.0M$8.0M$8.0M$7.0M$4.0M$1.0M$0
Reserves$14.0M$17.0M$17.0M$19.0M$25.0M$25.0M$32.0M$31.0M$37.0M$48.0M

For Pro-Dex, Inc., operating cash flow was positive in 7 of 10 reported years; free cash flow in the latest year was $7.0M; free cash flow was positive in 7 of 10 years; financing activities used $3.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Operating Cash Flow$3.0M$3.0M$3.0M$6.0M−$1.0M−$1.0M$5.0M$6.0M−$2.0M$7.0M
Investing Cash Flow−$2.0M−$5.0M−$3.0M−$4.0M−$3.0M−$3.0M−$2.0M−$3.0M−$1.0M$3.0M
Financing Cash Flow$0$0−$4.0M−$3.0M−$10.0M−$2.0M−$2.0M−$3.0M−$4.0M−$3.0M
Net Cash Flow$2.0M$1.0M$3.0M−$1.0M−$3.0M−$3.0M$2.0M$0−$2.0M$8.0M
Free Cash Flow$3.0M$2.0M$2.0M$5.0M−$3.0M−$3.0M$4.0M$5.0M−$3.0M$7.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.66
EV / EBITDA16.78
FCF Yield3.11%
Quick Ratio2.46
Interest Coverage13.00
Return 1Y103.32%
Return 3Y262.16%
Return 5Y201.66%

Pro-Dex, Inc. (PDEX) financials — frequently asked questions

What is Pro-Dex, Inc.'s annual revenue?

Pro-Dex, Inc. (PDEX) reported annual revenue of $78.0M in its most recent fiscal year.

What is Pro-Dex, Inc.'s net profit?

Pro-Dex, Inc. (PDEX) reported net profit of $14.0M in its most recent fiscal year.

What is PDEX EV/EBITDA?

Pro-Dex, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 16.78.

Revenue and earnings of other Medical - Instruments & Supplies stocks

BDX revenue $19.5BMDLN stockWST revenue $3.1BSOLV revenue $8.3BBAX revenue $11.2BCOO revenue $4.1BRGEN revenue $738.0MAVTR revenue $6.6BATR revenue $3.8BBLCO revenue $5.1BAll Medical - Instruments & Supplies stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
PDEX Overview PDEX Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.